RELATIONSHIP BETWEEN EXTRACELLULAR 5-HYDROXYTRYPTAMINE AND BEHAVIOR FOLLOWING MONOAMINE-OXIDASE INHIBITION AND L-TRYPTOPHAN

被引:58
作者
SLEIGHT, AJ
MARSDEN, CA
MARTIN, KF
PALFREYMAN, MG
机构
[1] QUEENS MED CTR,SCH MED,DEPT PHYSIOL & PHARMACOL,NOTTINGHAM NG7 2UH,ENGLAND
[2] MERRELL DOW RES INST,CINCINNATI,OH 45215
基金
英国惠康基金;
关键词
D O I
10.1111/j.1476-5381.1988.tb11435.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:303 / 310
页数:8
相关论文
共 28 条
[1]   INCREASED TOTAL ACTIVITY IN THE RAT AFTER L-TRYPTOPHAN PLUS THE MONOAMINE OXIDASE-A INHIBITOR AMIFLAMINE BUT NOT AFTER L-TRYPTOPHAN PLUS CLORGYLINE [J].
ARCHER, T ;
FOWLER, CJ ;
FREDRIKSSON, A ;
LEWANDER, T ;
MAGNUSSON, O ;
MOHRINGE, B ;
SODERBERG, U .
BRITISH JOURNAL OF PHARMACOLOGY, 1985, 85 (03) :581-590
[2]   THE 5-HT1 RECEPTOR AGONIST RU-24969 DECREASES 5-HYDROXYTRYPTAMINE (5-HT) RELEASE AND METABOLISM IN THE RAT FRONTAL-CORTEX INVITRO AND INVIVO [J].
BRAZELL, MP ;
MARSDEN, CA ;
NISBET, AP ;
ROUTLEDGE, C .
BRITISH JOURNAL OF PHARMACOLOGY, 1985, 86 (01) :209-216
[3]   EFFECTS OF PUTATIVE 5-HYDROXYTRYPTAMINE ANTAGONISTS ON BEHAVIOR PRODUCED BY ADMINISTRATION OF TRANYLCYPROMINE AND L-TRYPTOPHAN OR TRANYLCYPROMINE AND L-DOPA TO RATS [J].
DEAKIN, JFW ;
GREEN, AR .
BRITISH JOURNAL OF PHARMACOLOGY, 1978, 64 (02) :201-209
[4]   DEAMINATION OF 5-HYDROXYTRYPTAMINE BY BOTH FORMS OF MONOAMINE-OXIDASE IN THE RAT-BRAIN [J].
FOWLER, CJ ;
TIPTON, KF .
JOURNAL OF NEUROCHEMISTRY, 1982, 38 (03) :733-736
[6]   EFFECTS OF MONOAMINE-OXIDASE INHIBITION BY CLORGYLINE, DEPRENIL OR TRANYLCYPROMINE ON 5-HYDROXYTRYPTAMINE CONCENTRATIONS IN RAT-BRAIN AND HYPERACTIVITY FOLLOWING SUBSEQUENT TRYPTOPHAN ADMINISTRATION [J].
GREEN, AR ;
YOUDIM, MBH .
BRITISH JOURNAL OF PHARMACOLOGY, 1975, 55 (03) :415-422
[7]  
GREEN AR, 1976, NATURE, V260, P487
[8]   SINGLE AND REPEATED ADMINISTRATION OF NEUROLEPTIC DRUGS TO RATS - EFFECTS ON STRIATAL DOPAMINE-SENSITIVE ADENYLATE-CYCLASE AND LOCOMOTOR ACTIVITY PRODUCED BY TRANYLCYPROMINE AND L-TRYPTOPHAN OR L-DOPA [J].
HEAL, DJ ;
GREEN, AR ;
BOULLIN, DJ ;
GRAHAMESMITH, DG .
PSYCHOPHARMACOLOGY, 1976, 49 (03) :287-300
[9]  
HESS SM, 1961, ARCH INT PHARMACOD T, V134, P89
[10]  
IRONS J, 1984, NEUROBIOLOGY TRACE A, P423